Schedule 13D ownership disclosure
FUSION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 36118A100
Event date: 2020-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,621,436
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-006307
- Form type
- SC 13D
- Filer
- Fusion Pharmaceuticals Inc.
- CIK
- CIK 1805890
- Filed
- Jul 10, 2020
- Reporting period
- Jun 30, 2020
- Description
- Schedule 13D beneficial ownership